Keyphrases
Renoprotective Effect
100%
Acute Decompensated Heart Failure
100%
Type 2 Diabetic Patients
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Estimated Glomerular Filtration Rate
80%
B-type Natriuretic Peptide
60%
Renin-angiotensin System Inhibitors
60%
Type 2 Diabetic Mellitus
40%
Detailed Mechanism
20%
HbA1c Levels
20%
Hospitalization
20%
Renal Function
20%
Patients with Chronic Heart Failure
20%
Renal Outcome
20%
Renal Function Improvement
20%
Baseline HbA1c
20%
Renal Endpoints
20%
Decline in Kidney Function
20%
Baseline Factors
20%
12-month Follow-up
20%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Decompensated Heart Failure
100%
Glomerular Filtration Rate
80%
Kidney Function
60%
Brain Natriuretic Peptide
60%
Renin-Angiotensin System Inhibitor
60%
Diabetes Mellitus
40%
Hemoglobin A1c
20%
Congestive Heart Failure
20%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Non Insulin Dependent Diabetes Mellitus
100%
Brain Natriuretic Peptide
60%
Renin-Angiotensin System Inhibitor
60%
Diabetes Mellitus
40%
Hemoglobin A1c
20%
Biochemistry, Genetics and Molecular Biology
Sodium-Glucose Cotransporter 2 Inhibitors
100%
Glomerulus Filtration
80%
Kidney Function
60%
Renin Angiotensin Aldosterone System
60%
Blood Plasma
60%
Brain Natriuretic Peptide
60%